Michael Kallay, MD
University Of Rochester Medical Center
Michael Kallay, MD, is Associate Professor of Medicine at the University of Rochester. His expertise is in asthma, exercise physiology and COPD, and interstitial lung diseases and his research interest in the management of interstitial lung diseases. Dr. Kallay has been a principal investigator in over 20 clinical trials in the areas of clinical interest above. Dr. Kallay maintains a strong interest in clinical trials involving patients with idiopathic pulmonary fibrosis. (This is me - Update Profile)
| 1981 - present | Associate Professor of Medicine University Of Rochester Medical Center |
|---|
GLG Study Groups with Michael Kallay, MD(?)
| Study Group Name | Members |
|---|---|
| Physicians who Treat Asthma (US) | 456 |
| Pulmonologists (US) | 752 |
| Physicians in the U.S. who Treat Chronic Obstructive Pulmonary Disease (COPD) | 215 |
| Xolair Prescribers for Asthma (US) | 65 |
GLG NewsSM Analyses by Michael Kallay, MD(?)
This will be an important addition for COPD. The nebulized form of a long acting bronchodilator will be valuable for patients who like nebulized administration. Additionally, the Arformoterol does not have the L isomer- is this the molecule that has lead to increased deaths with Serevent? ...
GLG InstituteSM Seminars with Michael Kallay, MD(?)
View all GLG InstituteSM Seminars in Healthcare
Request a project with Michael Kallay, MD
Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms